Wouter van Dijk
Papers
2
Total Citations
127
H-Index
2
About
Wouter van Dijk is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for esophageal cancer treatment. His landmark contribution is the ROBOT randomized clinical trial, which demonstrated that robot-assisted minimally invasive thoraco-laparoscopic esophagectomy (RAMIE) significantly reduces postoperative complications compared to open transthoracic esophagectomy (OTE). This pivotal study, published in 2018 and cited over 100 times, has reshaped surgical standards for resectable esophageal cancer. Van Dijk further strengthened the case for RAMIE through a comprehensive cost analysis of the ROBOT trial, showing that the robotic approach is not only clinically superior but also economically viable. His work bridges the gap between surgical innovation and practical healthcare economics, providing robust evidence for the adoption of robotic surgery in high-volume centers. With a citation impact exceeding 125 across his most-cited papers, van Dijk’s research has influenced both clinical practice and health policy. His contributions are particularly valuable for surgeons and trainees seeking to understand the evidence base for minimally invasive esophagectomy, as he combines rigorous trial methodology with real-world applicability.
Research Focus
Key Achievements
Top Papers
- 1
- 2